Position in INCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$437,116
-$698,724 QoQ
Shares Held
3,856
-68.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#547
of 855 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CSS LLC/IL holds $23,787,576 across 16 Biotechnology names. INCY ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
152,289 | $12,074,994 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
29,041 | $6,998,009 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
22,580 | $1,292,027 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,820 | $1,134,842 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
6,520 | $510,320 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
8,470 | $481,180 | |
| 7 | EXEL |
Exelixis, Inc.
|
8,709 | $473,856 | |
| 8 | INCY |
Incyte Corp
This page
|
3,856 | $437,116 |
All Filings in INCY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $437,116 | 3,856 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,135,840 | 12,068 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $923,400 | 9,349 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $992,955 | 11,708 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $667,243 | 9,798 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $495,904 | 8,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $686,555 | 9,940 | Shares | Sole | 2025-02-18 | |
| 2023-09-30 | $361,120 | 6,251 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||